Concepedia

Anne-Sophie Delvigne

AD

Statistics

Publications

3

Citations

77

H-Index

3

Active since

2016

Affiliations

University of Namur(Current)

University of Liège

Anne-Sophie Delvigne is an author at University of Namur specializing in pharmacology, drug delivery, and oncology.

Publications per year

2016–2020

3

Publications

3

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impact on Endothelial Cells: An In-Vitro Study

Hélène Haguet, Céline Bouvy, Anne-Sophie Delvigne et al. · Frontiers in Pharmacology · 2020 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies

Claudio Palazzo, Julie Laloy, Anne-Sophie Delvigne et al. · European Journal of Pharmaceutical Sciences · 2018 · 23 citations

Pharmacy, Pharmaceutics, Pharmacology +17

PEGylated and Functionalized Aliphatic Polycarbonate Polyplex Nanoparticles for Intravenous Administration of HDAC5 siRNA in Cancer Therapy

Antoine Frère, Alexandra Baroni, Elodie Hendrick et al. · ACS Applied Materials & Interfaces · 2016 · 22 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–3 of 3